86 related articles for article (PubMed ID: 329811)
1. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
Oliveira JM
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
[No Abstract] [Full Text] [Related]
2. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
[No Abstract] [Full Text] [Related]
3. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
[No Abstract] [Full Text] [Related]
4. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
[No Abstract] [Full Text] [Related]
5. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
[No Abstract] [Full Text] [Related]
6. Effects of drugs upon exercise tests in coronary insuffiency.
Oliveira JM
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():79-81. PubMed ID: 329813
[No Abstract] [Full Text] [Related]
7. [Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
Candau LA; Pereira LS; Lavall MA; Carvalho CR
Arq Bras Cardiol; 1982 Aug; 39(2):135-8. PubMed ID: 6763518
[No Abstract] [Full Text] [Related]
8. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
[No Abstract] [Full Text] [Related]
9. [Effect of verapamil on the cycloergometric test in patients with coronary artery disease (complementary study)].
Martins de Oliveira J
Arq Bras Cardiol; 1979 Feb; 32(2):135-7. PubMed ID: 464855
[No Abstract] [Full Text] [Related]
10. [Verapamil in the treatment of angina pectoris. Double-blind study with clinical-cycloergometric correlation].
Maranhão MF; Lopes M; Toledo MT; Rojas RI; Michelotto PV; Michelotto PV; Lacerda FS; Furlan L; Cunha GP; Oliveira PF
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():95-9. PubMed ID: 329814
[No Abstract] [Full Text] [Related]
11. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
[No Abstract] [Full Text] [Related]
12. [Use of verapamil in the treatment of ventricular extrasystole in chronic Chagas' heart disease].
Vichi FL; Nobre F; Evora P; Ribeiro PJ; Papa MV
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():101-6. PubMed ID: 407891
[No Abstract] [Full Text] [Related]
13. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
Ribeiro JM; Sadi J; Barros FA
Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
[No Abstract] [Full Text] [Related]
14. [Exertion-electrocardiographic and hemodynamic studies with oral verapamil in chronic ischemic heart disease].
Assmann I; Schwela H; Oltmanns G; Fiehring H
Z Gesamte Inn Med; 1978 May; 33(10):300-3. PubMed ID: 98925
[TBL] [Abstract][Full Text] [Related]
15. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
Furkalo NK; Zaĭtseva VI
Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
[No Abstract] [Full Text] [Related]
16. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
Castro I; Pereira FA; Rodrigues R
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
[No Abstract] [Full Text] [Related]
17. [Clinical and cycloergometric evaluation of verapamil in the therapeutic of angina pectoris].
Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():65-70. PubMed ID: 329810
[No Abstract] [Full Text] [Related]
18. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
Goch JH; Rec A; Bala T
Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
[No Abstract] [Full Text] [Related]
19. [Verapamil in a single dose, evaluation by means of the ergometric test].
Pereira MH; Brito FS; Pereira CB; Lion MF
Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():83-94. PubMed ID: 889475
[No Abstract] [Full Text] [Related]
20. The effect of verapamil in patients with asymptomatic stress-induced ischemia.
Zilberman A; Rogel S
Arch Intern Med; 1989 May; 149(5):1062-4. PubMed ID: 2719499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
